CPD Courses
Registration of Medicinal Products Based on Monoclonal Antibodies.
Online Course • grapl
About the CPD course
This module addresses characteristic issues influencing the registration of medicinal products based on monoclonal antibodies (mAbs); for use in humans. We focus on distinctive issues in the production and testing of mAbs; in the context of relevant regulatory guidance. We discuss manufacturing quality; nonclinical; and clinical issues. We address aspects specific to radio labelled mAbs. Finally; we identify the pathways for applications to conduct clinical trials and to market mAb-based products in Europe and the USA.
Send an enquiry
grapl
grapl is a UK based digital learning and development specialist, authoring and designing Zenosis® courses to provide an extensive eLearning library for the pharmaceutical, biotech and medicinal products sector. This learning can be delivered via the customers LMS, the grapl LMS or its social, knowledge and collaborative CloudRooms platform. Continuously updated to reflect regulatory changes, Zenosis® courses are trusted to educate their people by some of the worlds leading companies.
Want to learn more?
More CPD courses by grapl
Education
An Introduction to Drug Safety and Pharmacovigilan...
grapl
Drug safety monitoring and risk management are vitally important for medicinal product developers; l...
Online Course
Education
An Introduction to Clinical Trials and Drug Develo...
grapl
This course provides an understanding of how clinical trials fit into the drug development process....
Online Course
Education
An Introduction to Clinical Trial Preparation and...
grapl
Worldwide expenditure on R&D by the pharmaceutical industry is continually increasing. Most of the f...
Online Course
Education
ICH Good Clinical Practice
grapl
Good Clinical Practice (GCP) is a set of internationally recognised ethical and scientific quality r...
Online Course
Get industry-related content straight to your inbox
Thank you for subscribing
By signing up to our site you are agreeing to our privacy policy